Merck & Company, Inc. News Headlines

MRK 
$57.61
*  
0.98
1.73%
Get MRK Alerts
*Delayed - data as of Oct. 24, 2014  -  Find a broker to begin trading MRK now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
ESPR Prices Stock Offering At $20/Share
10/15/2014 8:52:00 PM - RTT News


Dogs Of The Dow: 2014 Third Quarter Review
10/15/2014 4:14:00 PM - Seeking Alpha


Cramer: The Bearâ??s on the Move -- and the Panic Is Palpable
10/15/2014 1:20:00 PM - TheStreet


Gilead's Harvoni Will Dominate J&J's Olysio In HCV: Is Olysio Even Relevant Anymore?
10/15/2014 9:24:00 AM - Seeking Alpha


Johnson & Johnson and Bristol-Myers Squibb’s New Collaboration Just the Tip of the Iceberg
10/15/2014 8:45:02 AM - Motley Fool


Merck Still Looks Very Expensive
10/14/2014 3:02:00 PM - Seeking Alpha


Can Dividend Stock GlaxoSmithKline plc Bounce Back?
10/14/2014 1:09:05 PM - Motley Fool


How Retirees Made It Through The Last 2 Recessions
10/14/2014 11:41:00 AM - Seeking Alpha


Merck: Be Prepared For A Buying Opportunity From A Dividend Perspective
10/14/2014 8:03:00 AM - Seeking Alpha


Notable Two Hundred Day Moving Average Cross - MRK
10/13/2014 4:01:53 PM - BNK Invest


Dow Movers: MRK, TRV
10/13/2014 1:43:41 PM - BNK Invest


A Quick Look at Merck & Co. Inc.'s Drug Development Pipeline
10/13/2014 12:41:02 PM - Motley Fool


Gilead Sciences Inc. Gets First Hepatitis C Cocktail Drug Approved
10/10/2014 5:18:02 PM - Motley Fool


Merck Becomes #21 Most Shorted Dow Stock, Replacing Chevron
10/10/2014 9:36:58 AM - BNK Invest


iShares U.S. Healthcare ETF Experiences Big Inflow
10/9/2014 11:05:17 AM - BNK Invest


Why companies like BAE and Bayer issued debt in US markets
10/9/2014 9:00:00 AM - Market Realist


Weighting Your Dividend Growth Stocks
10/9/2014 8:13:00 AM - Seeking Alpha


Bristol Myers Squibb Getting Close To Lung Cancer Approval For Nivolumab
10/8/2014 1:52:49 PM - Trefis


Dow Movers: DD, MRK
10/8/2014 11:42:14 AM - BNK Invest


Bristol-Myers Tells Gilead Sciences, Inc. "You Win"
10/8/2014 11:05:02 AM - Motley Fool


Called Strike 3 For Bristol-Myers Squibb: What This Says For Gilead And Its Competitors In The Hep C Market
10/8/2014 10:51:00 AM - Seeking Alpha


Should Pfizer Inc. Buy This Surprisingly Competitive Biotech Stock?
10/7/2014 8:30:16 AM - Motley Fool


HCV: The 'C' Stands For Cure
10/7/2014 1:31:00 AM - Seeking Alpha


Merck Prices EUR 2.5 Bln Debt Offering
10/6/2014 1:04:00 PM - RTT News


Comparing America's 3 Largest Drug Manufacturers
10/6/2014 11:53:00 AM - Seeking Alpha